Wedbush initiated coverage on Oculis Holding AG with a new price target
$OCS
Biotechnology: Pharmaceutical Preparations
Health Care
Wedbush initiated coverage of Oculis Holding AG with a rating of Outperform and set a new price target of $27.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/5/2023 | $30.00 | Buy | Chardan Capital Markets |
| 10/5/2023 | $35.00 | Buy | Stifel |
| 6/14/2023 | $22.00 | Buy | BofA Securities |
| 6/12/2023 | $28.00 | Buy | H.C. Wainwright |
| 6/8/2023 | $58.00 | Outperform | Robert W. Baird |
| 5/10/2023 | $23.00 | Buy | Pareto |
| 4/28/2023 | $27.00 | Outperform | Wedbush |
ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) ("Oculis" or the "Company"), today announced the results from its 2025 Annual General Meeting held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT. The Company's shareholders approved all agenda items. The shareholders approved the 2024 Annual Report including the 2024 Annual (Statutory) Financial Statements and the 2024 Consolidated Financial Statements. The shareholders acknowledged that on a standalone statutory financial statement basis, the Company incurred a loss of CHF 5,179,000 with respect to the financial year ended December 31, 2024, and
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced that Oculis will be participating in the following upcoming investor conferences: Goldman Sachs Annual Healthcare ConferenceJune 9-11; Miami, FL, U.S.Fireside chat with Riad Sherif, MD, Chief Executive Officer, on June 10th from 9:20 to 9:55am ET. J.P. Morgan European Healthcare Conference June 12; London, U.K.Riad Sherif, MD, Chief Executive Officer, will be attending. The Company will be available for one-on-one meetings dur
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) ("Oculis"), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT. The 2025 Annual General Meeting will be held in-person and broadcast. To join the broadcast, please use the following link. Information pertaining to the 2025 Annual General Meeting, including meeting materials, can be accessed on the Oculis website here. Oculis will host a virtual information session for all shareholders on May 19, 2025 from 4:00 to 5:00 p.m. CEST / 10:00 to 11:00 a.m. EDT, during
Chardan Capital Markets initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $30.00
Stifel initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $35.00
BofA Securities initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $22.00
S-8 - Oculis Holding AG (0001953530) (Filer)
6-K - Oculis Holding AG (0001953530) (Filer)
6-K - Oculis Holding AG (0001953530) (Filer)